Eye conjuctivitis

Reference

1. Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology 2017;124:1099–1107.
2. Bedside diagnosis of the "Red Eye": a systematic review by Narayana S and McGee S. 2015;128:1220–1224.e1221. Am J Med.
3. Woodland RM, Darougar S, Thaker U, Cornell L,  Siddique M, Wania J, et al. Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan. Trans Royal Soc Trop Med Hygiene 1992;86:317–320.
4. Everitt H, Little P. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam Pract 2002;19:658–660.
5. Friedlaender MH. Ocular allergy. Curr Opin Allergy Cli Immunol 2011;11:477–48
6. Bielory L, Frohman LP. Allergic and immunologic disorder of the eye. J Allergy Clin Immunol 1992;89:1–15.
7. Rietveld RP, van Weert HC, ter Riet G, Bindels PJ. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis: systematic literature search. BM 2003;327:78
8. Drew RJ, Cole TS, Newman W. How to use… eye swabs Arch Dis Child Educ Pract Ed 2015;100:155–161
9. Wong VW, Lai TY, Chi SC, Lam DS. Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment. Cornea 2011;30:995–1002.
10. Kam KY, Ong HS, Bunce C, Ogunbowale L, Verma S. Sensitivity and specificity of the Adeno Plus point-of-care system in detecting adenovirus in conjunctivitis patient at an ophthalmic emergency department: a diagnost accuracy study. Br J Ophthalmol 2015;99:1186–1189
11. Newman H, Gooding C. Viral ocular manifestations: a broad overview. Rev Med Virol 2013;23:281–294.
12. Singh G, Zhou X, Lee JY, Yousuf MA, Ramke M, Ismail AM, et al. Recombination of the epsilon determinant and corneal tropism: human adenovirus species D types 15, 29, 56, and 69. Virology 2015;485:452–459,
13. Harley D, Harrower B, Lyon M, Dick A. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Comm Dis Intell 2001;25:9–12
14. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leede MacDougall R. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Can J Ophthalmol 2002;37:228–237; discussion 237.
15. Bremond-Gignac D, Mariani-Kurkdjian P, Beresniak A, El Fekih L, Bhagat Y, Pouliquen P, et al. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients. Pediatr Infect Dis J 2010;29:222–226.
16. Puri LR, Shrestha GB, Shah DN, Chaudhary M, Thakur A. Ocular manifestations in herpes zoster ophthalmicus. Nepal J Ophthalmol 2011;3:165–171.
17. Zhang L, Zhao N, Huang X, Jin X, Geng X, Chan TC, et al. Molecular epidemiology of acute hemorrhagic conjunctivitis caused by coxsackie a type 24 variant in China, 2004-2014. Sci Rep 2017;7:45202
18. Serin S, Bozkurt Oflaz A, Karabagli P, Gedik S, Bozkurt B. Eyelid molluscum contagiosum lesions in two patients with unilateral chronic conjunctivitis. Turk J Ophthalmol  2017;47:226–230.
19. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacteria  conjunctivitis. Am J Ophthalmol 1991;112:29s–33s.
20. Hovding G. Acute bacterial conjunctivitis. Acta Ophthalmol 2008;86:5–17
21. Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract 2004;54:451–456.
22. Maziak W, Behrens T, Brasky TM, Duhme H, Rzehak P Weiland SK, et al. Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Munster, Germany. Allergy 2003;58:572–579.